Facebook
Twitter
LinkedIn
ForwardGlycemic Control Optimization Strategies
Avoidable hypoglycemia and hyperglycemia events in hospitalized patients have been identified as an area of opportunity by the Centers of Medicare and Medicaid Services. Staring in the year 2023 a new Electronic Clinical Quality Measure (eCQM) reportable to CMS has gone into effect. This webinar aims to provide an update about the new reportable quality measure and present contemporary approaches to glycemic control optimization by pharmacy departments in Academic Medical Center settings.
Target Audience
Pharmacists
Learning Objectives
Pharmacists learning objectives
At the conclusion of this activity, pharmacists should be able to:
- Discuss two new CMS-reportable quality measures for preventable glycemic events in the inpatient setting
- Describe two approaches to identifying, preventing, or managing hyper/hypoglycemia events in the inpatient setting.
- Name one attribute of a diabetes stewardship program.
Additional Information
Faculty
Daniel Kudryashov, PharmD, MHA, MSL, BCPS
Medication Safety Officer
Keck Medical Center of USC
Tricia Parker, PharmD, MS, BCPS, CPPS, FCCM, FIHI
Assistant Chief Pharmacy Officer
UC Davis Health
Steve Kim, PharmD, BCPS
Pharmacy Program Coordinator – Diabetes Stewardship
Cedars Sinai
Sonia Mathews, PharmD, MSHA, BCPS
Clinical Pharmacy Practice Specialist
UTMB Health
Melissa McKnight, PharmD, BCPS
Diabetes Stewardship coordinator
Nebraska Medicine
Planning committee
Sybil Thomas, PharmD, MBA
AVP, Member Connections
Vizient, Inc.
Daniel Kudryashov, PharmD, MHA, MSL, BCPS
Medication Safety Officer
Keck Medical Center of USC
Tricia Parker, PharmD, MS, BCPS, CPPS, FCCM, FIHI
Assistant Chief Pharmacy Officer
UC Davis Health
Donna Leang, PharmD, MHDS, BCPS, FCSHP
Medication Safety Manager
Cedars Sinai
Sonia Mathews, PharmD, MSHA, BCPS
Clinical Pharmacy Practice Specialist
UTMB Health
Molly Leber, PharmD, MBA, BCPS, FASHP
Associate Director, Drug Use Policy and Formulary Management
Yale New Haven Health
Identification, Mitigation, and Disclosure of Relevant Financial Relationships
As an accredited provider of continuing education, Vizient, Inc. is dedicated to ensuring this activity presents learners with only accurate, balanced, scientifically justified recommendations, and is free from promotion, marketing, and commercial bias. In accordance with The Standards for Integrity and Independence in Accredited Continuing Education, all planners, faculty, and others in control of the educational content have disclosed the absence or existence of all financial relationships (of any dollar amount) with ineligible companies within the past 24 months.
It is Vizient’s policy that owners and employees of ineligible companies, and any individuals who refuse to disclose the absence or existence of financial relationships with any ineligible companies are disqualified from participating as planners or faculty.
Disclosure of Relevant Financial Relationships:
Relevant Financial Relationships
Vizient, Inc., Jointly Accredited for Interprofessional Continuing Education, defines companies to be ineligible as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
An individual is considered to have a relevant financial relationship if the educational content an individual can control is related to the business lines or products of the ineligible company.
Daniel Kudryashov, PharmD, MHA, MSL, BCPS planner/speaker for this educational activity, is consultant for Ketchum, Inc.
All relevant financial relationships listed for these individual(s) have been mitigated.
All others in a position to control content for this educational activity have no relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Statement of Content Validity
Vizient, Inc. educational activities are intended to assist healthcare teams advance their professional responsibilities in accordance with the definition of continuing education. It is the policy of Vizient, Inc. to review and ensure that all content and recommendations for patient care within accredited CE is evidenced-based, based on current science and clinical reasoning while ensuring the content is fair and balanced. All recommendations must conform to the generally accepted standards of experimental design, data collection, analysis, and interpretation. Vizient, Inc. does not permit accredited continuing education if it advocates for unscientific approaches to diagnosis or therapy, or if the education promotes recommendations, treatment, or manners of practicing healthcare that are determined to have risks or dangers that outweigh the benefits or are known to be ineffective in the treatment of patients.
Disclaimer: The education provided through this activity is for continuing education purposes only. The views and opinions expressed in this activity are those of the faculty/presenters and do not necessarily reflect the views of Vizient, Inc.
In support of improving patient care, Vizient, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Designation Statement(s):
PHARMACY
Vizient, Inc. designates this activity for a maximum of 1.00 ACPE credit hours.
Universal Activity Number: JA0006103-0000-23-070-L04-P
OTHER
Vizient, Inc. will award all other healthcare professionals who successfully complete the activity a Certificate of Participation. Various state license boards and credentialing bodies accept certificates of participation from accredited CE activities to meet CE requirements for license renewals and re- certification. It is the responsibility of the participant to contact their state licensing board and/or certifying body for verification on credit eligibility reciprocity.
Available Credit
- 1.00 ACPE Pharmacist
- 1.00 General CE - Attendance